Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) Total Assets : ¥113,470 Mil (As of Dec. 2023)

View and export this data going back to 1998. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Total Assets?

Shanghai Fosun Pharmaceutical (Group) Co's Total Assets for the quarter that ended in Dec. 2023 was ¥113,470 Mil.

During the past 12 months, Shanghai Fosun Pharmaceutical (Group) Co's average Total Assets Growth Rate was 8.80% per year. During the past 3 years, the average Total Assets Growth Rate was 10.90% per year. During the past 5 years, the average Total Assets Growth Rate was 10.00% per year. During the past 10 years, the average Total Assets Growth Rate was 14.30% per year.

During the past 13 years, Shanghai Fosun Pharmaceutical (Group) Co's highest 3-Year average Total Assets Growth Rate was 91.20%. The lowest was 8.40%. And the median was 22.90%.

Total Assets is connected with ROA %. Shanghai Fosun Pharmaceutical (Group) Co's annualized ROA % for the quarter that ended in Dec. 2023 was 0.37%. Total Assets is also linked to Revenue through Asset Turnover. Shanghai Fosun Pharmaceutical (Group) Co's Asset Turnover for the quarter that ended in Dec. 2023 was 0.10.

Shanghai Fosun Pharmaceutical (Group) Co Total Assets Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Total Assets Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

76,119.65

83,686.01

93,306.32

107,163.91

113,469.61

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Assets	Get a 7-Day Free Trial															107,163.91	107,379.38	112,142.69	110,767.24	113,469.61

Shanghai Fosun Pharmaceutical (Group) Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Shanghai Fosun Pharmaceutical (Group) Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	56616.26	+	56853.344
	=	113,470

Shanghai Fosun Pharmaceutical (Group) Co's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	56616.26	+	56853.344
	=	113,470

Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) Total Assets Explanation

Total Assets is connected with ROA %.

Shanghai Fosun Pharmaceutical (Group) Co's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	412.8	/	( (110767.244	+	113469.605)	/ 2 )
	=	412.8	/	112118.4245
	=	0.37 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Shanghai Fosun Pharmaceutical (Group) Co's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	10699.421	/	( (110767.244	+	113469.605)	/ 2 )
=	10699.421	/	112118.4245
=	0.10

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Shanghai Fosun Pharmaceutical (Group) Co Total Assets Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) » Definitions » Total Assets

Traded in Other Exchanges

SFOSF:USA 02196:Hong Kong 08HH:Germany

Address

No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233

Website

https://www.fosunpharma.com

Shanghai Fosun Pharmaceutical (Group) Co Ltd is a specialty and generic drug manufacturing company. Shanghai Fosun maintains five business segments, including Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. Most of the company's revenue is generated by its Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) Headlines

No Headlines